In addition it addresses the FDA’s communications With all the applicant, the retention of information that aid the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer possession of an SE report back to a completely new applicant and Digital submission on the SE report and